was a good presentation. no doubt about the efficacy of the product. it is a game changer. not what big pharma wants though... product has too much potential.
smart move though, the company going to other countries for trials like Australia and India. I especially like them using the cro with access to international regions. India is tops on my list as they are much more independent.
Long term hold for me and attractive at this price.
News 
Market Data 
Discover 
AI
